New combination of a betablocker and a cholesterol-lowering agent

Details for Australian Patent Application No. 2001242985 (hide)

Owner AstraZeneca AB

Inventors Wikstrand, John; Wiklund, Olov; Bondjers, Goran

Agent Davies Collison Cave

Pub. Number AU-B-2001242985

PCT Pub. Number WO01/74394

Priority 0002352 22.06.00 SE; 0001188 03.04.00 SE

Filing date 27 March 2001

Wipo publication date 15 October 2001

Acceptance publication date 24 February 2005

International Classifications

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 003/06 Drugs for disorders of the metabolism

A61K 031/505 - Pyrimidines

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/195

Event Publications

24 February 2005 Application Accepted

  Published as AU-B-2001242985

23 June 2005 Standard Patent Sealed

15 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001242986

2001242984